MedPath

SYLVANT

SYLVANT

Approved
DIN Number

02435136

Drug Class

Human

Market Date

Mar 3, 2015

Company
HC

recordati rare diseases canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02435136
AIG Number0156310002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AC11 SILTUXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SILTUXIMABActive
Strength: 400 MG / VIAL
Monograph: SILTUXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.